Cargando…
Brain Endothelial P-Glycoprotein Level Is Reduced in Parkinson’s Disease via a Vitamin D Receptor-Dependent Pathway
The progressive neurodegeneration in Parkinson’s disease (PD) is accompanied by neuroinflammation and endothelial vascular impairment. Although the vitamin D receptor (VDR) is expressed in both dopamine neurons and brain endothelial cells, its role in the regulation of endothelial biology has not be...
Autores principales: | Kim, Hyojung, Shin, Jeong-Yong, Lee, Yun-Song, Yun, Seung Pil, Maeng, Han-Joo, Lee, Yunjong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696047/ https://www.ncbi.nlm.nih.gov/pubmed/33198348 http://dx.doi.org/10.3390/ijms21228538 |
Ejemplares similares
-
Therapeutic Evaluation of Synthetic Peucedanocoumarin III in an Animal Model of Parkinson’s Disease
por: Ham, Sangwoo, et al.
Publicado: (2019) -
Poly (ADP-ribose) in the pathogenesis of Parkinson's disease
por: Lee, Yunjong, et al.
Publicado: (2014) -
Hydrocortisone-induced parkin prevents dopaminergic cell death via CREB pathway in Parkinson’s disease model
por: Ham, Sangwoo, et al.
Publicado: (2017) -
VPS35 regulates parkin substrate AIMP2 toxicity by facilitating lysosomal clearance of AIMP2
por: Yun, Seung Pil, et al.
Publicado: (2017) -
Estrogen receptor activation contributes to RNF146 expression and neuroprotection in Parkinson's disease models
por: Kim, Hyojung, et al.
Publicado: (2017)